IGPH — IGEA Pharma NV Balance Sheet
0.000.00%
Last trade - 00:00
- CH₣0.51m
- CH₣0.90m
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.88 | 0.398 | 0.11 | 0.017 | 0.03 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.68 | 0.099 | 0.108 | 0.196 | 0.056 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.56 | 0.509 | 0.237 | 1.13 | 0.222 |
Net Property, Plant And Equipment | 0.09 | 0.076 | 0.02 | — | — |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 3.04 | 0.952 | 0.599 | 11.4 | 0.222 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.816 | 0.467 | 0.428 | 1.55 | 1.2 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 0.796 | 0.446 | 0.421 | 2.13 | 2.52 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2.24 | 0.506 | 0.178 | 9.32 | -2.3 |
Total Liabilities & Shareholders' Equity | 3.04 | 0.952 | 0.599 | 11.4 | 0.222 |
Total Common Shares Outstanding |